Personalized Medicine & Targeted Therapies
Personalized medicine and targeted therapies are reshaping cancer care by tailoring treatment strategies to the molecular and genetic characteristics of individual tumors. This approach uses biomarkers, genomic profiling, and molecular diagnostics to identify actionable targets and select therapies most likely to be effective. Targeted treatments, such as kinase inhibitors, hormone therapies, and monoclonal antibodies, disrupt specific pathways essential to cancer growth. Personalized medicine minimizes unnecessary side effects and increases therapeutic success rates by aligning treatment with patient-specific biology. It also supports adaptive treatment plans based on real-time monitoring through liquid biopsies and imaging.